Serum Circ‐ DLGAP4 and miR ‐9 as Potential Biomarkers in Pancreatic Cancer
Journal of Clinical Laboratory Analysis · 2025
DOI: 10.1002/jcla.70076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Marwa A Ali und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University, Fayoum, Egypt. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, MicroRNAs, Biomarkers, Tumor, RNA, Circular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Pancreatic cancer remains one of the malignancies characterized by the most insidious onset and dire prognosis. Preliminary diagnostic biomarkers are essential for timely identification and improved prognosis. CircularRNA‐DLGAP4 (Circ‐DLGAP4) and microRNA‐9 (miR‐9) are intriguing, easily accessible genetic indicators for numerous diseases.
Aim
To quantify serum expression levels of Circ‐DLGAP4 and miR‐9 in pancreatic cancer patients and juxtapose these values with those of control persons to assess their potential as diagnostic biomarkers. It also aims to correlate their expression levels with the clinicopathological features of the disease.
Method
Quantitative analysis of serum samples collected from 40 pancreatic cancer patients and 40 control subjects with RT‐PCR.
Results
There were statistically significant elevations in blood levels of Circ‐DLGAP4 and miR‐9 in pancreatic cancer patients compared to healthy persons, with median (range) values of 8.2 (0.39–17.32), p ‐value < 0.001, and 9.5 (4.06–14.7), respectively. The blood level of Circ‐DLGAP4 exhibited a significant positive correlation with the serum concentration of miR‐9 ( r = 0.89, p = 0.001).
Conclusions
Circ‐DLGAP4 and miR‐9 serve as diagnostic biomarkers for pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
- Department of Biomedical Sciences, College of Medicine, King Faisal University, Al-Ahsa, Kingdom of Saudi Arabia.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Internal Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
- Department of Medical Microbiology and Immunology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
- Department of Clinical and Chemical Pathology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
ORCID-Profile: Marwa A Ali, Olfat G Shaker, Omayma O Abdelaleem
Zitieren
APA
Ali, M. A., Shaker, O. G., Ezzat, E. M., Ahmed, M. S. Z., Elasmer, S. M., Abdelhafeez, M. M. A., Zaidan, M., El-Ela, R. Y. A., AbdelHafez, M. N., Fares, E., Al Abdulqader, A. A., Awaji, A. A., Alamoudi, M. K., & Abdelaleem, O. O. (2025). Serum Circ‐ DLGAP4 and miR ‐9 as Potential Biomarkers in Pancreatic Cancer. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70076
Vancouver
Ali MA, Shaker OG, Ezzat EM, Ahmed MSZ, Elasmer SM, Abdelhafeez MMA, et al. Serum Circ‐ DLGAP4 and miR ‐9 as Potential Biomarkers in Pancreatic Cancer. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70076
BibTeX
@article{Ali2025,
author = {Ali, Marwa A and Shaker, Olfat G and Ezzat, Eman M and Ahmed, Mohamed Saad Zaghloul and Elasmer, Shimaa Mohammed and Abdelhafeez, Marwa Mamdouh Ahmed and Zaidan, Mohamed and El-Ela, Raghda Yahia Abu and AbdelHafez, Marwa N and Fares, Eman and Al Abdulqader, Ahmad A and Awaji, Aeshah A and Alamoudi, Mariam K and Abdelaleem, Omayma O},
title = {Serum Circ‐ DLGAP4 and miR ‐9 as Potential Biomarkers in Pancreatic Cancer},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
doi = {10.1002/jcla.70076}
}
EUVIMED